Pilot Evaluation of a Psychoeducation Group for Family Caregivers of Children and Adolescents With Emotional and Behavioral Disorders (CPG-CA) in China

March 27, 2025 updated by: Hao YAO, Shanghai Mental Health Center

The goal of this waitlist-controlled randomized pilot trial is to premilinariliy learn if the CPG-CA internvention, a group psychoeducational intervention for family caregivers of children and adolescents with emotional and behavioral disorders, works to relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China. It will also learn about the acceptability of the CPG-CA intervention. The main questions it aims to answer are:

Does the CPG-CA intervention relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China? Is the CPG-CA intervention acceptable to family caregivers of children and adolescents with emotional and behavioral disorders in China?

Researchers will compare the CPG-CA intervention to care-as-usual to see if the CPG-CA internvention works to relieve caregiver burden among family caregivers of children and adolescents with emotional and behavioral disorders in China.

Participants will receive the CPG-CA intervention or care-as-usual for 12 weeks.

Study Overview

Detailed Description

In China, most children and adolescents with emotional and behavioral disorders (E/BDs) are living with families. With an extreme scarcity of child and adolescent mental health care resources in China, the primary caregiving responsibility for children and adolescents with E/BDs is laid on families. However, caregiving for children and adolescents with E/BDs could be challenging, and family caregivers of children and adolescents with E/BDs often describe their caregiving experiences as exhausting and burdensome.

To date, very few interventions in China have been designed to relieve caregiver burden among family caregivers of children and adolescents with E/BDs. Therefore, this study aims to conduct a randomized, wait-list controlled pilot trial to preliminarily evaluate the feasibility and effectiveness of the CPG-CA intervention, a group psychoeducational intervention for family caregivers of children and adolescents with E/BDs, in reducing caregiver burden among family caregivers of children and adolescents with E/BDs in China. This pilot trial will lay the groundwork for a major trial that will be conducted in future studies.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200030
        • Shanghai Mental Health Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Family caregivers of children and adolescents under the age of 18 with emotional and behavioral disorders;
  2. The child or adolescent must have a confirmed diagnosis of an emotional or behavioral disorder, including: emotional and behavioral disorders with onset usually occurring in childhood and adolescence, mood disorders, depressive disorders, bipolar disorder, anxiety disorders, attention-deficit/hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder, obsessive-compulsive disorder (OCD), eating disorders, schizophrenia, and addictive disorders;
  3. Providing care for a child or adolescent with an emotional or behavioral disorder for at least three months;
  4. Aged 18 or older;
  5. Able to provide informed consent.

Exclusion Criteria:

  1. Caregivers of children and adolescents with neurodevelopmental disorders (e.g., autism, intellectual disability);
  2. Paid caregivers;
  3. Caregivers with severe physical illnesses or mental disorders;
  4. Caregivers under the age of 18;
  5. Those unable to provide informed consent;
  6. Caregivers who are simultaneously participating in other support groups for family caregivers of children and adolescents with emotional and behavioral disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
The intervention group will first receive the CPG-CA intervention.
The CPG-CA intervention is a group psychoeducational internvention for family caregivers of children and adolescents with E/BDs in China. It will consist of 10 to 15 family caregivers of children and adolescents with E/BDs, meeting once a week for 1.5 to 2 hours per session, for a total of 12 sessions over a 3-month period. The sessions will cover the following themes: (1) knowledge about child and adolescent emotional and behavioral disorders; (2) coping skills for common emotional and behavioral problems in children and adolescents; (3) problem-solving skills; (4) communication skills with children and adolescents; (5) positive parenting techniques; and (6) self-care techniques. A variety of facilitation techniques will be used in the intervention, including didactic teaching, group discussion, role-playing, and homework assignment.
No Intervention: Waitlist control group
The waitlist control group will receive the CPG-CA intervention after the intervention group. During the waiting period, the waitlist control group will receive care as usual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver burden
Time Frame: Baseline (T0) and 3 months (T1)
Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).
Baseline (T0) and 3 months (T1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caregiver burden
Time Frame: Baseline (T0) and 6 months (T2)
Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).
Baseline (T0) and 6 months (T2)
Caregiver burden
Time Frame: Baseline (T0) and 9 months (T3)
Participants' caregiver burden will be assessed using the Zarit Burden Interview (ZBI).
Baseline (T0) and 9 months (T3)
Depression
Time Frame: Baseline (T0) and 3 months (T1)
Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).
Baseline (T0) and 3 months (T1)
Depression
Time Frame: Baseline (T0) and 6 months (T2)
Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).
Baseline (T0) and 6 months (T2)
Depression
Time Frame: Baseline (T0) and 9 months (T3)
Participants' depression will be assessed using the Patient Health Questionnaire (PHQ).
Baseline (T0) and 9 months (T3)
Anxiety
Time Frame: Baseline (T0) and 3 months (T1)
Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).
Baseline (T0) and 3 months (T1)
Anxiety
Time Frame: Baseline (T0) and 6 months (T2)
Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).
Baseline (T0) and 6 months (T2)
Anxiety
Time Frame: Baseline (T0) and 9 months (T3)
Participants' anxiety will be assessed using the Generalized Anxiety Disorder Scale (GAD).
Baseline (T0) and 9 months (T3)
Illness perception
Time Frame: Baseline (T0) and 3 months (T1)
Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).
Baseline (T0) and 3 months (T1)
Illness perception
Time Frame: Baseline (T0) and 6 months (T2)
Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).
Baseline (T0) and 6 months (T2)
Illness perception
Time Frame: Baseline (T0) and 9 months (T3)
Participants' illness perception will be assessed using the Brief Illness Perception Questionnaire (BIPQ).
Baseline (T0) and 9 months (T3)
Coping style
Time Frame: Baseline (T0) and 3 months (T1)
Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).
Baseline (T0) and 3 months (T1)
Coping style
Time Frame: Baseline (T0) and 6 months (T2)
Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).
Baseline (T0) and 6 months (T2)
Coping style
Time Frame: Baseline (T0) and 9 months (T3)
Participants' coping style will be assessed using the Simplified Coping Style Questionnaire (SCSQ).
Baseline (T0) and 9 months (T3)
Social support
Time Frame: Baseline (T0) and 3 months (T1)
Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).
Baseline (T0) and 3 months (T1)
Social support
Time Frame: Baseline (T0) and 6 months (T2)
Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).
Baseline (T0) and 6 months (T2)
Social support
Time Frame: Baseline (T0) and 9 months (T3)
Participants' social support will be assessed using the Oslo Social Support Scale (OSSS).
Baseline (T0) and 9 months (T3)
Positive caregiving experiences
Time Frame: Baseline (T0) and 3 months (T1)
Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).
Baseline (T0) and 3 months (T1)
Positive caregiving experiences
Time Frame: Baseline (T0) and 6 months (T2)
Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).
Baseline (T0) and 6 months (T2)
Positive caregiving experiences
Time Frame: Baseline (T0) and 9 months (T3)
Participants' positive caregiving experiences will be assessed using the Positive Aspect of Caregiving scale (PAC).
Baseline (T0) and 9 months (T3)
Feeling of hope
Time Frame: Baseline (T0) and 3 months (T1)
Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).
Baseline (T0) and 3 months (T1)
Feeling of hope
Time Frame: Baseline (T0) and 6 months (T2)
Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).
Baseline (T0) and 6 months (T2)
Feeling of hope
Time Frame: Baseline (T0) and 9 months (T3)
Participants' feeling of hope will be assessed using the Herth Hope Index (HHI).
Baseline (T0) and 9 months (T3)
Feeling of mastery
Time Frame: Baseline (T0) and 3 months (T1)
Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).
Baseline (T0) and 3 months (T1)
Feeling of mastery
Time Frame: Baseline (T0) and 6 months (T2)
Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).
Baseline (T0) and 6 months (T2)
Feeling of mastery
Time Frame: Baseline (T0) and 9 months (T3)
Participants' feeling of mastery will be assessed using the Pearlin Mastery Scale (PMS).
Baseline (T0) and 9 months (T3)
Self-stigma
Time Frame: Baseline (T0) and 3 months (T1)
Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).
Baseline (T0) and 3 months (T1)
Self-stigma
Time Frame: Baseline (T0) and 6 months (T2)
Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).
Baseline (T0) and 6 months (T2)
Self-stigma
Time Frame: Baseline (T0) and 9 months (T2)
Participants' self-stigma will be assessed using the stigma sub-scale of the Experiences of Caregiving Inventory (ECI).
Baseline (T0) and 9 months (T2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2025

Primary Completion (Estimated)

October 31, 2025

Study Completion (Estimated)

April 30, 2026

Study Registration Dates

First Submitted

March 19, 2025

First Submitted That Met QC Criteria

March 27, 2025

First Posted (Actual)

March 28, 2025

Study Record Updates

Last Update Posted (Actual)

March 28, 2025

Last Update Submitted That Met QC Criteria

March 27, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

In order to protect participants' privacy, IPD will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotional and Behavioral Disorders in Children and Adolescents

Clinical Trials on Caregiver Psychoeducation Group for Children and Adolescents with Emotional and Behavioral Disorders (CPG-CA)

Subscribe